Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
537
datasets available to search
ShareScore release 0.9.0
Dataset results
537 results for “Pharmaceuticals”
Supplementary material 1 from: Golembiovska О, Voskoboinik O, Berest G, Kovalenko S, Logoyda L (2021) Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1. Pharmacia 68(1): 79-87. https://doi.org/10.3897/pharmacia.68.e50704
Shimadzu LCsolution Analysis Report
Data from: Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: a qualitative study
Background: Studies around the world have shown that interactions between pharmaceutical companies, pharmacists and physicians have a great influence on prescribing and drug dispensing practices. In middle-income countries, the nature and extent of these interactions have not been well researched. Our objectives were to qualitatively explore the nature of the interactions between pharmaceutical companies, physicians and pharmacists, their impact on drug prescription and dispensing practices in Lebanon. Methods and Findings: We used grounded theory approach as well as the known sponsor, purposive, and snowballing sampling strategies to identify interviewees from the three respective groups: physicians, pharmacists, and pharmaceutical representatives. We conducted semi-structured and analyzed transcripts thematically. 6 pharmaceutical representatives, 13 physicians and 13 pharmacists participated in the study. The following themes emerged: purpose and driver for the interactions, nature of the interactions, incentives, impact on prescription practices, ethical considerations, and suggestions for managing the interactions. The main purposes for the interaction were educational, promotional, and monitoring prescription practices and dispensing, while the main drivers for these interactions were market potential and neighborhood socio-economic status. Physicians, pharmacists and pharmaceutical representatives who engage in these interactions benefit from a variety of incentives, some of which were characterized as unethical. It appears that pharmaceutical companies give prominence to selected physicians within their communities. Although members of the three interviewed groups refer to some of the interactions as being problematic, they described a culture of acceptance of gift giving. We developed a framework that depicts the prevailing politico-cultural environment, the interactions between the three professional groups, and their impact on drug prescription. Underreporting is the main limitation of this study. Conclusion: Interactions between physicians, pharmacists and pharmaceutical representatives are frequent. Although these interactions can be beneficial, they still have a substantial effect on drug prescription and dispensing practices. Hence, the need for new policies that regulate these interactions and penalize any misconduct.
The method and data for Efficiency Evaluation of Listed Pharmaceutical Companies in China Using Three-Stage DEA with PCA Integration
<p>The method and data used for this article</p>
Scheme 1 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Scheme 1 Proposal of the reaction pathway between valsartan and BPB with formation Valsartan-Bromphenol blue complex.
Figure 7 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 7 Absolute values ∆ A of the difference in the absorption of valsartan with MR in different solvents with the absorption of MR in different solvents.
Scheme 2 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Scheme 2 Proposal of the reaction pathway between valsartan and MR with formation Valsartan-Methyl red ion pair associates.
Figure 5 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 5 Absolute values ∆ A of the difference in the absorption of valsartan with BPB in different solvents with the absorption of BPB in different solvents.
Figure 15 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 15 Graph of the dependence of the adsorption of the reaction product of valsartan with MR on time.
Figure 14 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 14 Graph of the dependence of the adsorption of the reaction product of valsartan with BPB on time.
Figure 13 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 13 Absorption spectra of MR and valsartan with MR under conditions of studying the amount of added MR.
Figure 12 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 12 Absorption spectra of BPB and valsartan with BPB under conditions of studying the amount of added BPB.
Figure 9 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 9 Plot of Job's method for determination of molar ratio of the formed Valsartan-MR ion pair complex.
Figure 8 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 8 Plot of Job's method for determination of molar ratio of the formed Valsartan-BPB ion pair complex.
Optimizing the selection of drug-polymer-water formulations for spray-dried solid dispersions in pharmaceutical manufacturing
<p>The files contain 2 MINLP formulations and supplementary material discussed in this publication. The MINLP problems are implemented and solved in GAMS version 36.2.0, using SBB and SCIP, a local and global MINLP solver, respectively.</p>
Supplementary material 1 from: Castaño Sánchez A, Pereira J, Gonçalves F, Reboleira A (2018) Comparative acute toxicity of the pharmaceutical compound Diclofenac on groundwater and surface water crustaceans. ARPHA Conference Abstracts 1: e29822. https://doi.org/10.3897/aca.1.e29822
Poster presented at the 24th International Conference on Subterranean Biology. University of Aveiro (Portugal), 20-24th August 2018.
Dataset: Tarsus Pharmaceuticals, Inc. (TARS) Stock Performance
This dataset provides historical stock market performance data for specific companies. It enables users to analyze and understand the past trends and fluctuations in stock prices over time. This information can be utilized for various purposes such as investment analysis, financial research, and market trend forecasting.
Dataset: Rhythm Pharmaceuticals, Inc. (RYTM) Stock Performance
This dataset provides historical stock market performance data for specific companies. It enables users to analyze and understand the past trends and fluctuations in stock prices over time. This information can be utilized for various purposes such as investment analysis, financial research, and market trend forecasting.
Dataset: Rigel Pharmaceuticals, Inc. (RIGL) Stock Performance
This dataset provides historical stock market performance data for specific companies. It enables users to analyze and understand the past trends and fluctuations in stock prices over time. This information can be utilized for various purposes such as investment analysis, financial research, and market trend forecasting.
Dataset: Hepion Pharmaceuticals, Inc. (HEPA) Stock Performance
This dataset provides historical stock market performance data for specific companies. It enables users to analyze and understand the past trends and fluctuations in stock prices over time. This information can be utilized for various purposes such as investment analysis, financial research, and market trend forecasting.
Support Data Operational Efficiency of Pharmaceutical Companies in China Based on Three Stage DEA with Undesirable Outputs Model.
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.